{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:15:49Z","timestamp":1788304549658,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":70,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_46","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:38:12Z","timestamp":1788302292000},"page":"773-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Erythrocyte Membrane Alloantigens"],"prefix":"10.1007","author":[{"given":"Kashyap R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Jajosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin L.","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"6","key":"46_CR1","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","volume":"10","author":"F Pirenne","year":"2023","unstructured":"Pirenne F, Floch A, Diop S (2023) Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries. Lancet Haematol 10(6):e468\u2013e476","journal-title":"Lancet Haematol"},{"issue":"25","key":"46_CR2","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","volume":"131","author":"F Pirenne","year":"2018","unstructured":"Pirenne F, Yazdanbakhsh K (2018) How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions. Blood 131(25):2773\u20132781","journal-title":"Blood"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathol-012414-040318","volume":"10","author":"JC Zimring","year":"2015","unstructured":"Zimring JC, Spitalnik SL (2015) Pathobiology of transfusion reactions. Annu Rev Pathol 10:83\u2013110","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"46_CR4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/ajh.24908","volume":"92","author":"D Narbey","year":"2017","unstructured":"Narbey D et al (2017) Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease. Am J Hematol 92(12):1340\u20131348","journal-title":"Am J Hematol"},{"issue":"5","key":"46_CR5","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1111\/trf.15227","volume":"59","author":"CL Dean","year":"2019","unstructured":"Dean CL et al (2019) Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients. Transfusion 59(5):1698\u20131705","journal-title":"Transfusion"},{"issue":"2","key":"46_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","volume":"25","author":"JR Storry","year":"2009","unstructured":"Storry JR, Olsson ML (2009) The ABO blood group system revisited: a review and update. Immunohematology 25(2):48\u201359","journal-title":"Immunohematology"},{"issue":"8","key":"46_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood.2022018903","volume":"142","author":"SC Wu","year":"2023","unstructured":"Wu SC et al (2023) Blood group a enhances SARS-CoV-2 infection. Blood 142(8):742\u2013747","journal-title":"Blood"},{"issue":"4","key":"46_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101704","volume":"298","author":"AV Blenda","year":"2022","unstructured":"Blenda AV et al (2022) Galectin-9 recognizes and exhibits antimicrobial activity toward microbes expressing blood group-like antigens. J Biol Chem 298(4):101704","journal-title":"J Biol Chem"},{"issue":"5","key":"46_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100747","volume":"23","author":"HM Jan","year":"2024","unstructured":"Jan HM et al (2024) Galectin-4 antimicrobial activity primarily occurs through its C-terminal domain. Mol Cell Proteomics 23(5):100747","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"46_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.tmrv.2019.09.007","volume":"33","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Bartolucci P, Pirenne F (2019) The role of complement in post-transfusion hemolysis and hyperhemolysis reaction. Transfus Med Rev 33(4):225\u2013230","journal-title":"Transfus Med Rev"},{"issue":"2","key":"46_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","volume":"26","author":"NS Merle","year":"2019","unstructured":"Merle NS et al (2019) Complement activation during intravascular hemolysis: implication for sickle cell disease and hemolytic transfusion reactions. Transfus Clin Biol 26(2):116\u2013124","journal-title":"Transfus Clin Biol"},{"issue":"2","key":"46_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tracli.2019.03.002","volume":"26","author":"S Chonat","year":"2019","unstructured":"Chonat S et al (2019) Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Transfus Clin Biol 26(2):130\u2013134","journal-title":"Transfus Clin Biol"},{"issue":"13","key":"46_CR13","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1073\/pnas.1814797116","volume":"116","author":"NS Merle","year":"2019","unstructured":"Merle NS et al (2019) P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4\/heme-dependent manner. Proc Natl Acad Sci USA 116(13):6280\u20136285","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"46_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104211","volume":"52","author":"DY Chang","year":"2023","unstructured":"Chang DY et al (2023) The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease. Presse Med 52(4):104211","journal-title":"Presse Med"},{"issue":"3","key":"46_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3324\/haematol.2022.281050","volume":"108","author":"C Falguiere","year":"2023","unstructured":"Falguiere C et al (2023) Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France. Haematologica 108(3):889\u2013894","journal-title":"Haematologica"},{"issue":"3","key":"46_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3324\/haematol.2019.224709","volume":"105","author":"SL Thein","year":"2020","unstructured":"Thein SL et al (2020) Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal. Haematologica 105(3):539\u2013544","journal-title":"Haematologica"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","volume":"2009","author":"D Brinc","year":"2009","unstructured":"Brinc D, Lazarus AH (2009) Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematology Am Soc Hematol Educ Program 2009:185\u2013191","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"46_CR18","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.4049\/jimmunol.1302287","volume":"193","author":"H Yu","year":"2014","unstructured":"Yu H et al (2014) Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. J Immunol 193(6):2902\u20132910","journal-title":"J Immunol"},{"issue":"2","key":"46_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/trf.14452","volume":"58","author":"HC Sullivan","year":"2018","unstructured":"Sullivan HC et al (2018) Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion. Transfusion 58(2):542\u2013544","journal-title":"Transfusion"},{"issue":"5","key":"46_CR20","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.4049\/jimmunol.1500790","volume":"195","author":"L Bernardo","year":"2015","unstructured":"Bernardo L et al (2015) IgG-mediated immune suppression to erythrocytes by polyclonal antibodies can occur in the absence of activating or inhibitory Fcgamma receptors in a full mouse model. J Immunol 195(5):2224\u20132230","journal-title":"J Immunol"},{"issue":"8","key":"46_CR21","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","volume":"122","author":"SR Stowell","year":"2013","unstructured":"Stowell SR et al (2013) Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model. Blood 122(8):1494\u20131504","journal-title":"Blood"},{"issue":"10","key":"46_CR22","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.3324\/haematol.2015.128603","volume":"100","author":"SR Stowell","year":"2015","unstructured":"Stowell SR et al (2015) Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model. Haematologica 100(10):e394\u2013e397","journal-title":"Haematologica"},{"issue":"8","key":"46_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1182\/blood-2016-07-724989","volume":"128","author":"SR Stowell","year":"2016","unstructured":"Stowell SR (2016) Working together to block alloimmunization. Blood 128(8):1029\u20131030","journal-title":"Blood"},{"issue":"5","key":"46_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bjh.13339","volume":"169","author":"JB Vidler","year":"2015","unstructured":"Vidler JB et al (2015) Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br J Haematol 169(5):746\u2013753","journal-title":"Br J Haematol"},{"issue":"1","key":"46_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/hematology.2023000499","volume":"2023","author":"F Pirenne","year":"2023","unstructured":"Pirenne F, Pondarre C (2023) Alloimmunization and hyperhemolysis in sickle cell disease. Hematology Am Soc Hematol Educ Program 2023(1):653\u2013659","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"807","key":"46_CR26","doi-asserted-by":"publisher","first-page":"eadl4922","DOI":"10.1126\/scitranslmed.adl4922","volume":"17","author":"S Chonat","year":"2025","unstructured":"Chonat S et al (2025) Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Sci Transl Med 17(807):eadl4922","journal-title":"Sci Transl Med"},{"key":"46_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100593","volume":"38","author":"EK Storch","year":"2019","unstructured":"Storch EK et al (2019) Review of current transfusion therapy and blood banking practices. Blood Rev 38:100593","journal-title":"Blood Rev"},{"issue":"3","key":"46_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tmrv.2014.04.008","volume":"28","author":"JE Hendrickson","year":"2014","unstructured":"Hendrickson JE, Tormey CA, Shaz BH (2014) Red blood cell alloimmunization mitigation strategies. Transfus Med Rev 28(3):137\u2013144","journal-title":"Transfus Med Rev"},{"issue":"11","key":"46_CR29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/vox.13361","volume":"117","author":"C Gassner","year":"2022","unstructured":"Gassner C et al (2022) International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: update on blood group systems. Vox Sang 117(11):1332\u20131344","journal-title":"Vox Sang"},{"issue":"1","key":"46_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.htct.2018.06.006","volume":"41","author":"MG Quirino","year":"2019","unstructured":"Quirino MG et al (2019) Methods for blood group antigens detection: cost-effectiveness analysis of phenotyping and genotyping. Hematol Transfus Cell Ther 41(1):44\u201349","journal-title":"Hematol Transfus Cell Ther"},{"issue":"4","key":"46_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cll.2022.09.016","volume":"42","author":"JK Cone Sullivan","year":"2022","unstructured":"Cone Sullivan JK, Gleadall N, Lane WJ (2022) Blood group genotyping. Clin Lab Med 42(4):645\u2013668","journal-title":"Clin Lab Med"},{"issue":"4","key":"46_CR32","first-page":"319","volume":"20","author":"M Raos","year":"2022","unstructured":"Raos M et al (2022) The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia. Blood Transfus 20(4):319\u2013328","journal-title":"Blood Transfus"},{"issue":"6","key":"46_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/MOH.0b013e328311f40a","volume":"15","author":"EA Hod","year":"2008","unstructured":"Hod EA, Zimring JC, Spitalnik SL (2008) Lessons learned from mouse models of hemolytic transfusion reactions. Curr Opin Hematol 15(6):601\u2013605","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"46_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1423-0410.2010.01327.x","volume":"99","author":"EA Hod","year":"2010","unstructured":"Hod EA et al (2010) Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang 99(2):99\u2013111","journal-title":"Vox Sang"},{"issue":"10","key":"46_CR35","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3324\/haematol.2023.282815","volume":"108","author":"TA Thomas","year":"2023","unstructured":"Thomas TA et al (2023) Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica 108(10):2639\u20132651","journal-title":"Haematologica"},{"issue":"8","key":"46_CR36","doi-asserted-by":"publisher","first-page":"e167665","DOI":"10.1172\/JCI167665","volume":"134","author":"A Jash","year":"2024","unstructured":"Jash A et al (2024) Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. J Clin Invest 134(8):e167665","journal-title":"J Clin Invest"},{"issue":"3","key":"46_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/trf.17251","volume":"63","author":"CL Maier","year":"2023","unstructured":"Maier CL et al (2023) Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice. Transfusion 63(3):457\u2013462","journal-title":"Transfusion"},{"issue":"2","key":"46_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1182\/bloodadvances.2020002695","volume":"5","author":"CM Arthur","year":"2021","unstructured":"Arthur CM et al (2021) Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Adv 5(2):527\u2013538","journal-title":"Blood Adv"},{"issue":"5","key":"46_CR39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/trf.16872","volume":"62","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion 62(5):948\u2013953","journal-title":"Transfusion"},{"issue":"2","key":"46_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/bloodadvances.2017010124","volume":"2","author":"SR Patel","year":"2018","unstructured":"Patel SR et al (2018) Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice. Blood Adv 2(2):105\u2013115","journal-title":"Blood Adv"},{"issue":"2","key":"46_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bjh.17480","volume":"194","author":"M Tamagne","year":"2021","unstructured":"Tamagne M et al (2021) Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization. Br J Haematol 194(2):477\u2013481","journal-title":"Br J Haematol"},{"issue":"2","key":"46_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.2020008511","volume":"137","author":"M Pal","year":"2021","unstructured":"Pal M et al (2021) Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease. Blood 137(2):269\u2013280","journal-title":"Blood"},{"issue":"11","key":"46_CR43","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3324\/haematol.2015.132738","volume":"100","author":"E Godefroy","year":"2015","unstructured":"Godefroy E et al (2015) TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization. Haematologica 100(11):1415\u20131425","journal-title":"Haematologica"},{"issue":"1","key":"46_CR44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/voxs.12296","volume":"12","author":"K Yazdanbakhsh","year":"2017","unstructured":"Yazdanbakhsh K, Shaz BH, Hillyer CD (2017) Immune Regulation of sickle Cell Alloimmunization. ISBT Sci Ser 12(1):248\u2013253","journal-title":"ISBT Sci Ser"},{"key":"46_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3389\/fimmu.2018.00676","volume":"9","author":"A Mener","year":"2018","unstructured":"Mener A et al (2018) Complement component 3 negatively regulates antibody response by modulation of red blood cell antigen. Front Immunol 9:676","journal-title":"Front Immunol"},{"issue":"9","key":"46_CR46","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3324\/haematol.2016.147181","volume":"101","author":"E Godefroy","year":"2016","unstructured":"Godefroy E et al (2016) Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization. Haematologica 101(9):1028\u20131038","journal-title":"Haematologica"},{"issue":"22","key":"46_CR47","doi-asserted-by":"publisher","first-page":"e121631","DOI":"10.1172\/jci.insight.121631","volume":"3","author":"A Mener","year":"2018","unstructured":"Mener A et al (2018) Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses. JCI Insight 3(22):e121631","journal-title":"JCI Insight"},{"issue":"23","key":"46_CR48","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","volume":"130","author":"PE Zerra","year":"2017","unstructured":"Zerra PE et al (2017) Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A. Blood 130(23):2559\u20132568","journal-title":"Blood"},{"issue":"9","key":"46_CR49","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood.2020009210","volume":"139","author":"CM Arthur","year":"2022","unstructured":"Arthur CM et al (2022) Nonhuman glycans can regulate anti-factor VIII antibody formation in mice. Blood 139(9):1312\u20131317","journal-title":"Blood"},{"key":"46_CR50","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3389\/fimmu.2020.00905","volume":"11","author":"PE Zerra","year":"2020","unstructured":"Zerra PE et al (2020) Fc gamma receptors and complement component 3 facilitate anti-fVIII antibody formation. Front Immunol 11:905","journal-title":"Front Immunol"},{"issue":"14","key":"46_CR51","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","volume":"127","author":"CM Arthur","year":"2016","unstructured":"Arthur CM et al (2016) CD8+ T cells mediate antibody-independent platelet clearance in mice. Blood 127(14):1823\u20131827","journal-title":"Blood"},{"issue":"11","key":"46_CR52","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.3324\/haematol.2016.149278","volume":"101","author":"A Arneja","year":"2016","unstructured":"Arneja A et al (2016) Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica 101(11):e440\u2013e444","journal-title":"Haematologica"},{"key":"46_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629608","volume":"12","author":"A Jash","year":"2021","unstructured":"Jash A et al (2021) Antibodies to low-copy number RBC alloantigen convert a tolerogenic stimulus to an immunogenic stimulus in mice. Front Immunol 12:629608","journal-title":"Front Immunol"},{"issue":"21","key":"46_CR54","first-page":"2642","volume":"141","author":"R Jajosky","year":"2023","unstructured":"Jajosky R et al (2023) Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice. Blood 141(21):2642\u20132653","journal-title":"Blood"},{"issue":"8","key":"46_CR55","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2020009376","volume":"138","author":"PE Zerra","year":"2021","unstructured":"Zerra PE et al (2021) Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice. Blood 138(8):706\u2013721","journal-title":"Blood"},{"issue":"23","key":"46_CR56","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","volume":"322","author":"EP Vichinsky","year":"1990","unstructured":"Vichinsky EP et al (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322(23):1617\u20131621","journal-title":"N Engl J Med"},{"issue":"6","key":"46_CR57","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","volume":"122","author":"ST Chou","year":"2013","unstructured":"Chou ST et al (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122(6):1062\u20131071","journal-title":"Blood"},{"issue":"1","key":"46_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bjh.19837","volume":"206","author":"J Wolf","year":"2024","unstructured":"Wolf J et al (2024) Red cell specifications for blood group matching in patients with haemoglobinopathies: an updated systematic review and clinical practice guideline from the international collaboration for transfusion medicine guidelines. Br J Haematol 206(1):94\u2013108","journal-title":"Br J Haematol"},{"issue":"1","key":"46_CR59","first-page":"3","volume":"5","author":"G Reali","year":"2007","unstructured":"Reali G (2007) Forty years of anti-D immunoprophylaxis. Blood Transfus 5(1):3\u20136","journal-title":"Blood Transfus"},{"issue":"9","key":"46_CR60","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1182\/blood.2023020860","volume":"143","author":"Y Cruz-Leal","year":"2024","unstructured":"Cruz-Leal Y et al (2024) Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression. Blood 143(9):807\u2013821","journal-title":"Blood"},{"key":"46_CR61","doi-asserted-by":"publisher","first-page":"1475470","DOI":"10.3389\/fimmu.2024.1475470","volume":"15","author":"RP Jajosky","year":"2024","unstructured":"Jajosky RP et al (2024) Dynamics of antibody engagement of red blood cells in vivo and in vitro. Front Immunol 15:1475470","journal-title":"Front Immunol"},{"issue":"4","key":"46_CR62","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/trf.16309","volume":"61","author":"Y Cruz-Leal","year":"2021","unstructured":"Cruz-Leal Y, Lazarus AH (2021) Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression? Transfusion 61(4):1004\u20131006","journal-title":"Transfusion"},{"issue":"6","key":"46_CR63","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/MOH.0000000000000374","volume":"24","author":"Y Cruz-Leal","year":"2017","unstructured":"Cruz-Leal Y, Marjoram D, Lazarus AH (2017) Prevention of hemolytic disease of the fetus and newborn: what have we learned from animal models? Curr Opin Hematol 24(6):536\u2013543","journal-title":"Curr Opin Hematol"},{"issue":"26","key":"46_CR64","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1182\/blood-2016-06-724732","volume":"128","author":"J Liu","year":"2016","unstructured":"Liu J et al (2016) Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice. Blood 128(26):3159\u20133168","journal-title":"Blood"},{"issue":"21","key":"46_CR65","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","volume":"2","author":"CL Maier","year":"2018","unstructured":"Maier CL et al (2018) Antibody-mediated immune suppression by antigen modulation is antigen-specific. Blood Adv 2(21):2986\u20133000","journal-title":"Blood Adv"},{"key":"46_CR66","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fimmu.2020.01516","volume":"11","author":"P Shinde","year":"2020","unstructured":"Shinde P et al (2020) IgG subclass determines suppression versus enhancement of humoral alloimmunity to Kell RBC antigens in mice. Front Immunol 11:1516","journal-title":"Front Immunol"},{"issue":"1","key":"46_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/trf.14939","volume":"59","author":"A Mener","year":"2019","unstructured":"Mener A et al (2019) Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcgamma receptors in mice. Transfusion 59(1):371\u2013384","journal-title":"Transfusion"},{"issue":"12","key":"46_CR68","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood.2022018591","volume":"142","author":"RP Jajosky","year":"2023","unstructured":"Jajosky RP, Patel KR, JWL A, Zerra PE, Chonat S, Ayona D, Maier CL, Morais D, Wu SC, Luckey CJ, Eisenbarth SC, Roback JD, Fasano RM, Josephson CD, Manis JP, Chai L, Hendrickson JE, Hudson KE, Arthur CM, Stowell SR (2023) Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood 142(12):1082\u20131098","journal-title":"Blood"},{"key":"46_CR69","doi-asserted-by":"crossref","unstructured":"Mohanty JG et al (2010) Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci 8:11","DOI":"10.1186\/1477-5956-8-11"},{"key":"46_CR70","unstructured":"Barker R N et al (1993) Identification of murine erythrocyte autoantigens and cross-reactive rat antigens. Immunology 78(4):568\u2013573"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:38:14Z","timestamp":1788302294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_46","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}